AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTEAgeX Therapeutics, Inc. • November 14th, 2023 • Pharmaceutical preparations • New York
Company FiledNovember 14th, 2023 Industry JurisdictionThis Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note (this “Amendment”) by and between AgeX Therapeutics Inc., a Delaware corporation (“Borrower”) and Juvenescence Limited, a company incorporated in the Isle of Man (“Lender”) is effective as of November 9, 2023 (“Effective Date”).
AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTEAgeX Therapeutics, Inc. • November 14th, 2023 • Pharmaceutical preparations • New York
Company FiledNovember 14th, 2023 Industry JurisdictionThis Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note (this “Amendment”) by and between AgeX Therapeutics Inc., a Delaware corporation (“Borrower”) and Juvenescence Limited, a company incorporated in the Isle of Man (“Lender”) is effective as of November 9, 2023 (“Effective Date”).